Dr. Cush

Rheumnow Podcast

Health EN ↓ 999 episodes

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

Author

Dr. Cush

Episodes

Count Your Telangiectasias (5.29.2026) 29.05.2026 20:02

Dr. Jack Cush reviews the news, journal articles and missed quiz question.

Quiz Talk (5.22.2026) 22.05.2026 24:42

Dr. Jack Cush talks of birthdays, Quizes and journal articles this week on the podcast.

Infectious Rheumatology (5.15.2026) 15.05.2026 30:15

Dr. Jack Cush discusses his favorite journal articles from the past week on RheumNow.com.

Influential Rheumatoid Factors(5/8/2026) 08.05.2026 22:20

Dr Jack Cush reviews the news and journal reports from last weekon rheumnow.com

Great Lectures; Great Presentations 01.05.2026 27:45

Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.

DERM on RheumNow (April 2026) 01.05.2026 15:43

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328...

Follow the Money (4.23.2026) 24.04.2026 25:58

Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week.

Prescribing Lessons (4.17.2026) 17.04.2026 25:05

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

Top Four and More (4.10.2026) 10.04.2026 25:58

Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week - including his top four favorite subjects.

Whats New PsA? (4.3.2026) 03.04.2026 20:59

Dr. Jack Cush reviews the news and major articles from this week, including FDA safety warnings, reports from AAD, PsA trials.

Addressing PsA GRAPPA Domains With a JAKi 01.04.2026 18:06

Dr. Schwartzman and Dr. Ruderman discuss the importance of a domain-based approach in PsA management and consider the potential role of a JAK inhibitor. Sponsored by AbbVie Medical Affairs + Health Impact. https://buff.ly/9gUnxB7

Moral Distress (3.27.2026) 27.03.2026 26:41

Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we discuss moral distress, FM in PsA, Lyme Vax is back & hidden but tangible benefits of the MDHAQ.

DERM on RheumNow Podcast (March 2026) 27.03.2026 14:40

This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia? Show Notes: 1. FDA Approves Icotrokinra for Plaque Psoriasis The FDA approved an oral IL-23 inhibitor, icotrokinra (Icotyde), for use in moderate-to-severe plaque psoriasis in adults and children 12 years of age and older who a...

Pitfalls in Rheumatology (3.20.2026) 20.03.2026 26:37

Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past week on RheumNow.com

STEP Talks from RNL26 Part #2 20.03.2026 56:57

STEP: Obesity and Inflammation: Weight management in Rheumatology. Dr. Uzma Haque STEP: Mitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery. Dr. Susan Goodman

STEP Talks from RNL26 Part #1 20.03.2026 42:25

STEP: Disease Modification in OA - Dr. Tuhina Neogi STEP: History of Gout - Dr. Robert Terkeltaub

Rheumatoid Arthritis Faculty Panel Q&A 20.03.2026 32:20

Rheumatoid Arthritis Faculty Panel Q&A

ILD in RA - Recent Advances. Dr. Jeffrey Sparks 20.03.2026 30:36

ILD in RA - Recent Advances. Dr. Jeffrey Sparks

The Mucosal Hypothesis of Rheumatoid Arthritis. Dr. Kristin Demoruelle 20.03.2026 31:52

The Mucosal Hypothesis of Rheumatoid Arthritis. Dr. Kristin Demoruelle

Mortality in Rheumatoid Arthritis: A Story of Decline, Delay, or Plateau? Dr. Elena Myasoedova 20.03.2026 30:54

Mortality in Rheumatoid Arthritis: A Story of Decline, Delay, or Plateau? Dr. Elena Myasoedova

Poets Know It (3.13.2026) 13.03.2026 25:59

Dr. Jack Cush reviews the news, regulatory decisions and new journal articles.

UBER Rheumatology Ride (3.6.2026) 06.03.2026 31:03

Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com

Early Decisions and Impact: An IL-23 Inhibitor in Bio-Naive Patients With PsA 02.03.2026 13:35

Sponsored by AbbVie Medical Affairs + Health Impact 

DERM on RheumNow PODCAST (February 2026) 28.02.2026 12:25

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. SHOW NOTES FDA sent a complete response letter to AstraZeneca on their application (BLA) for anifrolu...

SATISFACTION (2.27.2026) 27.02.2026 24:57

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com